News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Smith & Nephew Endoscopy (SNN) Awarded Contract From Healthtrust Purchasing Group


2/1/2010 8:29:21 AM

ANDOVER, Mass., Feb. 1 /PRNewswire-FirstCall/ -- Smith & Nephew's ; Endoscopy Division today announced that the company has been awarded a three-year contract (effective February 15, 2010) from HealthTrust Purchasing Group as a supplier of arthroscopic shaver blades to its membership nationwide. Smith & Nephew DYONICS(TM) shaver blades are used in hundreds of thousands of minimally invasive procedures each year to surgically treat injuries to the joint, such as an ACL tear in the knee or a frayed rotator cuff in the shoulder.

(TM) Trademark of Smith & Nephew

About Smith & Nephew

Smith & Nephew is a global medical technology business, specializing in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our operating margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

CONTACT: Joe Metzger, SVP, Corporate Communications, Smith & Nephew
Endoscopy, +1-978-749-1330, joe.metzger@smith-nephew.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES